Pharmafile Logo
Pharmafocus logo
Advanced Search

Antiverse

Showing 1 posts of 1 posts found.

Antiverse receive investment from IIC and Development Bank of Wales

March 9, 2026
Research and Development Antiverse, Wales, funding

As part of its $9.3m Series A funding round, Antiverse has received a joint equity investment by Innovation Investment Capital …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026